Company profile for Fractyl Health

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Fractyl Health is an organ editing metabolic therapeutics company focused on pioneering a new approach to the treatment of type 2 diabetes (T2D). Our goal is to transform T2D treatment from chronic blood glucose management to disease-modifying therapies that target the organ-level root causes of metabolic disease. We have assembled a mission-driven team full of innovators, united in a passion to eradicate type 2 diabetes and ...
Fractyl Health is an organ editing metabolic therapeutics company focused on pioneering a new approach to the treatment of type 2 diabetes (T2D). Our goal is to transform T2D treatment from chronic blood glucose management to disease-modifying therapies that target the organ-level root causes of metabolic disease. We have assembled a mission-driven team full of innovators, united in a passion to eradicate type 2 diabetes and to develop breakthrough therapies—the type of therapies we would want for our family members and loved ones with the disease.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
17 Hartwell Avenue Lexington, MA 02421
Telephone
Telephone
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

DDL Conference

Not Confirmed

envelop Contact Supplier

DDL Conference

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.globenewswire.com/news-release/2025/12/01/3196833/0/en/Fractyl-Health-to-Participate-in-the-8th-Annual-Evercore-Healthcare-Conference.html

GLOBENEWSWIRE
01 Dec 2025

https://www.globenewswire.com/news-release/2025/11/12/3186795/0/en/Fractyl-Health-Reports-Third-Quarter-2025-Results-Revita-Clinical-Momentum-Builds-Toward-2026-Pivotal-Readout-and-PMA-Filing-Cash-Runway-Extended-into-Early-2027.html

GLOBENEWSWIRE
12 Nov 2025

https://www.globenewswire.com/news-release/2025/11/05/3181253/0/en/Fractyl-Health-to-Report-Third-Quarter-2025-Financial-Results-and-Provide-Business-Updates-on-November-12-2025.html

GLOBENEWSWIRE
05 Nov 2025

https://www.globenewswire.com/news-release/2025/10/07/3162356/0/en/Fractyl-Health-Announces-Potent-Preclinical-Results-from-RJVA-002-a-Dual-GIP-GLP-1-Gene-Therapy-Candidate-for-Obesity.html

GLOBENEWSWIRE
07 Oct 2025

https://www.fiercebiotech.com/medtech/fractyl-health-delivers-data-its-procedure-maintaining-glp-1-weight-loss

FIERCE BIOTECH
30 Sep 2025

https://www.globenewswire.com/news-release/2025/09/26/3156951/0/en/Fractyl-Health-Announces-Pricing-of-60-Million-Underwritten-Offering-of-Common-Stock.html

GLOBENEWSWIRE
26 Sep 2025

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty